Fora Capital, LLC Revolution Medicines, Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $61,814 - $86,231	-2,581 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $74,849 - $122,442	2,581 New	2,581 $82 Million
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $166,998 - $244,281	-4,488 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $135,492 - $204,159	4,488 New	4,488 $177,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.86B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.